Dr Agarwal's Health Care provides a wide range of eye care services, including cataract and refractive surgeries, consultations, diagnostics, non-surgical treatments, and retail sales of optical ...

Dr Agarwal's Health Care raised ₹875.5 crore on Tuesday from 43 anchor investors, ahead of its IPO. The company sold 21.7 million shares at ₹402 apiece. Agencies Government of Singapore, Invesco India ...

Dr Agarwal's Health Care, supported by Temasek Holdings and TPG, has announced the raising of over Rs 875.5 crore from anchor investors prior to its initial public offering (IPO). Key investors ...

The promotor/promotors of Dr Agarwals Eye Hospital Ltd are Amar Agarwal., Athiya Agarwal, Sanjay Anand, Adil Agarwal, V Balakrishnan, Latha Ramanathan, Shiv Agrawal. What has been 52-week high of ...

Welcome to the part three of our wealth creator stocks (WC-stocks) series. In the first and second parts, released in the past two weeks, we discussed the top-10 multi-bagger stocks and analysed the ...

Initial public offer of up to 75,304,970 equity shares of face value of Re. 1/- each (Equity Shares) of Dr. Agarwal's Health Care Limited (Company) for cash at a price of Rs. 402.00 per equity share ...

Dr Agarwals Health Care, supported by Temasek Holdings and TPG, has secured over Rs 875.5 crore from anchor investors before its IPO. The Government of Singapore, Monetary Authority of Singapore ...

The initial share sale of Dr. Agarwal's Health Care Ltd, the eye care services provider backed by TPG and Temase, is set to open for public subscription on January 29 and will close on January 31.

Dr Agarwal’s Healthcare IPO opens for subscription on tomorrow (Wednesday, January 29). (https://www.dragarwal.com/) TPG and Temasek-backed Dr Agarwal’s ...

India right now has only 1.8-1.9 ophthalmologists for every 100,000 people, while the actual requirement is approximately 8-9 per 300,000 people, says Dr. Adil Agarwal, Whole-time Director and CEO of ...

Dr Agarwal Healthcare IPO opens January 29 at ₹382-402 per share. GMP trends lower at ₹15, signaling a 4% premium. High OFS component dampens growth prospects for the ₹3,027 crore issue. ETMarkets.com ...

The initial public offering of Dr Agarwal's Health Care Ltd. has been garnering decent interest from investors in the unlisted market, even before opening for subscription. The IPO of the eye care ...